Atkin SL - Search Results

1

Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome.

Butler AE, Hayat S, Dargham SR, Malek JA, Abdulla SA, Mohamoud YA, Suhre K, Sathyapalan T, Atkin SL. Butler AE, et al. Among authors: atkin sl. Clin Endocrinol (Oxf). 2019 Dec;91(6):793-797. doi: 10.1111/cen.14087. Epub 2019 Oct 1. Clin Endocrinol (Oxf). 2019. PMID: 31482638

2

Cytokine expression in human anterior pituitary adenomas.

Green VL, Atkin SL, Speirs V, Jeffreys RV, Landolt AM, Mathew B, Hipkin L, White MC. Green VL, et al. Among authors: atkin sl. Clin Endocrinol (Oxf). 1996 Aug;45(2):179-85. doi: 10.1046/j.1365-2265.1996.d01-1554.x. Clin Endocrinol (Oxf). 1996. PMID: 8881450

3

The biological variation of insulin resistance in polycystic ovarian syndrome.

Jayagopal V, Kilpatrick ES, Holding S, Jennings PE, Atkin SL. Jayagopal V, et al. Among authors: atkin sl. J Clin Endocrinol Metab. 2002 Apr;87(4):1560-2. doi: 10.1210/jcem.87.4.8404. J Clin Endocrinol Metab. 2002. PMID: 11932282

4

Somatostatin receptor 2 expression in the human endometrium through the menstrual cycle.

Green VL, Richmond I, Maguiness S, Robinson J, Helboe L, Adams IP, Drummond NS, Atkin SL. Green VL, et al. Among authors: atkin sl. Clin Endocrinol (Oxf). 2002 May;56(5):609-14. doi: 10.1046/j.1365-2265.2002.01521.x. Clin Endocrinol (Oxf). 2002. PMID: 12030911

5

The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance.

Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL. Jayagopal V, et al. Among authors: atkin sl. J Clin Endocrinol Metab. 2003 Apr;88(4):1528-33. doi: 10.1210/jc.2002-020557. J Clin Endocrinol Metab. 2003. PMID: 12679434

6

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

Jayagopal V, Kilpatrick ES, Holding S, Jennings PE, Atkin SL. Jayagopal V, et al. Among authors: atkin sl. J Clin Endocrinol Metab. 2005 Feb;90(2):729-33. doi: 10.1210/jc.2004-0176. Epub 2004 Nov 9. J Clin Endocrinol Metab. 2005. PMID: 15536162 Clinical Trial.

7

Key developments in endocrinology.

Mistry D, Maung KH, Manuchehri AM, Sathyapalan T, Atkin S, England J. Mistry D, et al. Practitioner. 2005 Aug;249(1673):541, 543-7, 549 passim. Practitioner. 2005. PMID: 16108472 Review. No abstract available.

8

The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome.

Cho LW, Jayagopal V, Kilpatrick ES, Holding S, Atkin SL. Cho LW, et al. Among authors: atkin sl. Ann Clin Biochem. 2006 May;43(Pt 3):217-9. doi: 10.1258/000456306776865188. Ann Clin Biochem. 2006. PMID: 16704758

9

Mechanism of action of octreotide in acromegalic tumours in vivo using dynamic contrast-enhanced magnetic resonance imaging.

Sathyapalan T, Lowry M, Turnbull LW, Rowland-Hill C, Atkin SL. Sathyapalan T, et al. Among authors: atkin sl. Pituitary. 2007;10(3):233-6. doi: 10.1007/s11102-007-0044-8. Pituitary. 2007. PMID: 17541750

10

Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI).

Manuchehri AM, Sathyapalan T, Lowry M, Turnbull LW, Rowland-Hill C, Atkin SL. Manuchehri AM, et al. Among authors: atkin sl. Pituitary. 2007;10(3):261-6. doi: 10.1007/s11102-007-0048-4. Pituitary. 2007. PMID: 17557207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

501 results

Search Page